Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3

Watchlist Manager
Hapvida Participacoes e Investimentos SA Logo
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
Watchlist
Price: 13.65 BRL 2.63% Market Closed
Market Cap: R$6.9B

P/OCF

3.1
Current
69%
Cheaper
vs 3-y average of 10.2

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
3.1
=
Market Cap
R$5B
/
Operating Cash Flow
R$2.1B

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
3.1
=
Market Cap
R$5B
/
Operating Cash Flow
R$2.1B

Valuation Scenarios

Hapvida Participacoes e Investimentos SA is trading below its 3-year average

If P/OCF returns to its 3-Year Average (10.2), the stock would be worth R$44.48 (226% upside from current price).

Statistics
Positive Scenarios
4/4
Maximum Downside
No Downside Scenarios
Maximum Upside
+355%
Average Upside
167%
Scenario P/OCF Value Implied Price Upside/Downside
Current Multiple 3.1 R$13.65
0%
3-Year Average 10.2 R$44.48
+226%
5-Year Average 14.3 R$62.09
+355%
Industry Average 3.3 R$14.42
+6%
Country Average 5.7 R$24.89
+82%

Forward P/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward P/OCF

Peer Comparison

All Multiples
P/OCF
P/E
All Countries
Close
P/E Multiple
Earnings Growth PEG
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
Average P/E: 19.7
Negative Multiple: -45.7
N/A N/A
US
UnitedHealth Group Inc
NYSE:UNH
26.7
22%
1.2
US
A
Anthem Inc
LSE:0HG8
15.8
10%
1.6
US
Elevance Health Inc
NYSE:ELV
13.4
10%
1.3
US
Humana Inc
NYSE:HUM
21.8
38%
0.6
US
Centene Corp
NYSE:CNC
Negative Multiple: -3.1 N/A N/A
US
Molina Healthcare Inc
NYSE:MOH
19
14%
1.4
US
Healthequity Inc
NASDAQ:HQY
32.6
32%
1
US
M
Magellan Health Inc
F:MAH1
8.5
N/A N/A
BR
Odontoprev SA
BOVESPA:ODPV3
14
4%
3.5
US
Progyny Inc
NASDAQ:PGNY
25.4
35%
0.7

Market Distribution

In line with most companies in Brazil
Percentile
31st
Based on 440 companies
31st percentile
3.1
Low
0.1 — 3
Typical Range
3 — 9.6
High
9.6 —
Distribution Statistics
Brazil
Min 0.1
30th Percentile 3
Median 5.7
70th Percentile 9.6
Max 2 583.6

Hapvida Participacoes e Investimentos SA
Glance View

Market Cap
6.9B BRL
Industry
Health Care

Hapvida Participações e Investimentos SA stands as a prominent player in Brazil's healthcare landscape, weaving an intricate tapestry of innovation and tradition in the nation's burgeoning private health sector. Headquartered in Fortaleza, this integrated health company began its journey in 1993. Initially, it was a small hospital that sought to address Brazil’s growing demand for accessible and comprehensive healthcare services. Over the years, Hapvida expanded its horizons by building a vast network that now includes hospitals, clinics, and laboratories scattered strategically across the country. This robust infrastructure forms the backbone of its operations, allowing the company to provide a seamless patient experience from diagnosis to aftercare. Driven by a commitment to technology, Hapvida harnesses advanced medical platforms to streamline its services, ensuring efficiency and cost-effectiveness, thus reinforcing its reputation as a leader in value-based healthcare. Hapvida’s business model thrives on vertical integration, a strategic choice that aligns various facets of healthcare delivery under one umbrella. This model not only enhances operational control but also reduces costs—a critical factor in a diverse and complex market like Brazil. By owning and managing its entire network of facilities, Hapvida enjoys significant bargaining power, enabling it to offer competitive pricing for its health plans. The company’s revenue is largely generated from these health insurance plans, which are marketed to individuals and corporate clients seeking affordable private healthcare options. Simultaneously, its owned hospitals and clinics serve as revenue streams through direct patient care services. Through this dual approach, Hapvida not only ensures steady income but also fortifies its standing as a trusted provider of health services, catering to millions and redefining the standards of private healthcare in Brazil.

HAPV3 Intrinsic Value
44.07 BRL
Undervaluation 69%
Intrinsic Value
Price R$13.65
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett